The Role of Data Mining in the Identification of Bioactive Compounds via High‐Throughput Screening

[1]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[2]  Christopher P Austin,et al.  High-throughput screening assays for the identification of chemical probes. , 2007, Nature chemical biology.

[3]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[4]  Ramesh Padmanabha,et al.  HTS quality control and data analysis: a process to maximize information from a high-throughput screen. , 2005, Combinatorial chemistry & high throughput screening.

[5]  Meir Glick,et al.  Enrichment of High-Throughput Screening Data with Increasing Levels of Noise Using Support Vector Machines, Recursive Partitioning, and Laplacian-Modified Naive Bayesian Classifiers , 2006, J. Chem. Inf. Model..

[6]  Ricardo Macarron,et al.  Critical review of the role of HTS in drug discovery. , 2006, Drug discovery today.

[7]  D. Bojanic,et al.  Impact of high-throughput screening in biomedical research , 2011, Nature Reviews Drug Discovery.

[8]  Ansgar Schuffenhauer,et al.  Rule‐Based Classification of Chemical Structures by Scaffold , 2011, Molecular informatics.

[9]  Robert P Bywater,et al.  Recognition of privileged structures by G-protein coupled receptors. , 2004, Journal of medicinal chemistry.

[10]  Natalia Markova,et al.  Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor. , 2010, Journal of medicinal chemistry.

[11]  M. Murcko,et al.  Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. , 1999, Journal of medicinal chemistry.

[12]  Robert Nadon,et al.  Statistical practice in high-throughput screening data analysis , 2006, Nature Biotechnology.

[13]  Lorenz M Mayr,et al.  The Future of High-Throughput Screening , 2008, Journal of biomolecular screening.

[14]  Meir Glick,et al.  Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases , 2006, J. Chem. Inf. Model..

[15]  John P Priestle.  3-D clustering: a tool for high throughput docking , 2009, Journal of molecular modeling.

[16]  M. Murcko,et al.  Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology. , 2008, Journal of medicinal chemistry.

[17]  Gavin Harper,et al.  Methods for mining HTS data. , 2006, Drug discovery today.

[18]  Stefan Wetzel,et al.  The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..

[19]  Marc W. Kirschner,et al.  Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling , 2009, Nature.

[20]  Robert P. Sheridan.  Finding Multiactivity Substructures by Mining Databases of Drug-Like Compounds , 2003, J. Chem. Inf. Comput. Sci..

[21]  Jordi Mestres,et al.  Identification of "latent hits" in compound screening collections. , 2003, Journal of medicinal chemistry.

[22]  Peter Ertl,et al.  Compound Set Enrichment: A Novel Approach to Analysis of Primary HTS Data , 2010, J. Chem. Inf. Model..

[23]  Xuefeng Bruce Ling.  High throughput screening informatics. , 2008, Combinatorial chemistry & high throughput screening.

[24]  Brian K Shoichet,et al.  A detergent-based assay for the detection of promiscuous inhibitors , 2006, Nature Protocols.

[25]  Vladimir Makarenkov,et al.  Using machine learning methods to predict experimental high-throughput screening data. , 2010, Combinatorial chemistry & high throughput screening.

[26]  Yun He,et al.  Learning from the Data: Mining of Large High-Throughput Screening Databases , 2006, J. Chem. Inf. Model..

[27]  Peter Meier,et al.  Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection. , 2005, Current topics in medicinal chemistry.

[28]  Peter Ertl,et al.  Mining for Bioactive Scaffolds with Scaffold Networks: Improved Compound Set Enrichment from Primary Screening Data , 2011, J. Chem. Inf. Model..

[29]  Wolfgang Guba,et al.  Development of a virtual screening method for identification of "frequent hitters" in compound libraries. , 2002, Journal of medicinal chemistry.

[30]  A. Bender,et al.  Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data , 2007, ChemMedChem.